SELCAMTA Trademark

Trademark Overview

On Thursday, July 26, 2018, a trademark application was filed for SELCAMTA with the United States Patent and Trademark Office. The USPTO has given the SELCAMTA trademark a serial number of 88054570. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, May 3, 2021. This trademark is owned by Shire International GmbH. The SELCAMTA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and injectables, namely, monoclonal antibody therapeutics for medical purposes, namely, the treatment of gastrointestinal and hepatological diseases and disorders
selcamta

General Information

Serial Number88054570
Word MarkSELCAMTA
Filing DateThursday, July 26, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, May 3, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 6, 2019

Trademark Statements

Goods and ServicesPharmaceutical preparations and injectables, namely, monoclonal antibody therapeutics for medical purposes, namely, the treatment of gastrointestinal and hepatological diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, August 1, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameShire International GmbH
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressZug 6300
CH
Party NameShire International GmbH
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressZug, 6300
CH

Trademark Events

Event DateEvent Description
Monday, May 3, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, May 3, 2021ABANDONMENT - NO USE STATEMENT FILED
Thursday, August 13, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 11, 2020EXTENSION 2 GRANTED
Tuesday, August 11, 2020EXTENSION 2 FILED
Tuesday, August 11, 2020TEAS EXTENSION RECEIVED
Wednesday, July 1, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, July 1, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, July 1, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, July 1, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, July 1, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, March 10, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 6, 2020EXTENSION 1 GRANTED
Friday, March 6, 2020EXTENSION 1 FILED
Friday, March 6, 2020TEAS EXTENSION RECEIVED
Tuesday, October 1, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 6, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 6, 2019PUBLISHED FOR OPPOSITION
Wednesday, July 17, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 2, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, June 17, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, June 17, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, June 15, 2019ASSIGNED TO LIE
Tuesday, June 11, 2019TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Monday, May 13, 2019NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Monday, May 13, 2019INQUIRY TO SUSPENSION E-MAILED
Monday, May 13, 2019SUSPENSION INQUIRY WRITTEN
Tuesday, November 13, 2018NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, November 13, 2018LETTER OF SUSPENSION E-MAILED
Tuesday, November 13, 2018SUSPENSION LETTER WRITTEN
Tuesday, November 13, 2018ASSIGNED TO EXAMINER
Wednesday, August 1, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, July 30, 2018NEW APPLICATION ENTERED IN TRAM

Related Keywords

selcamta namely gastrointestinal treatment hepatological purposes diseases disorders therapeutics injectables preparations